Platforms for Supporting iPSC-Based Allogeneic Therapy Development & Manufacturing
Time: 12:00 pm
day: Day One Track A AM
Details:
Following the success of RoslinCT’s recent iPSC webinar, Rowan Flynn, Principal Scientist, will describe platforms to enable IPSC derivation, gene editing, GMP cell banking and differentiation into chosen cell types.
